[{"id":"d64db104-1c14-4a1f-a553-5fd530a13586","acronym":"","url":"https://clinicaltrials.gov/study/NCT05275062","created_at":"2022-03-11T15:53:35.401Z","updated_at":"2024-07-02T16:36:15.601Z","phase":"Phase 1","brief_title":"Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma","source_id_and_acronym":"NCT05275062","lead_sponsor":"Beijing Immunochina Medical Science \u0026 Technology Co., Ltd.","biomarkers":" CLDN18 • CA 19-9","pipe":" | ","alterations":" CLDN18.2 positive","tags":["CLDN18 • CA 19-9"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CLDN18.2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IM92"],"overall_status":"Recruiting","enrollment":" Enrollment 6","initiation":"Initiation: 02/15/2022","start_date":" 02/15/2022","primary_txt":" Primary completion: 03/01/2024","primary_completion_date":" 03/01/2024","study_txt":" Completion: 05/01/2024","study_completion_date":" 05/01/2024","last_update_posted":"2022-03-11"}]